Clinical trial data from the SUSTAIN and STEP programs indicate that nausea, the most frequently reported side effect, generally improves within 46 weeks for most patients as tolerance develops
This is effectively identical to the meeting you would have with your doctor, with the exception that your regular doctor would know more about you at baseline
We then order a metabolic bloodwork panel that assesses key markers including fasting glucose, insulin levels, lipid profiles, thyroid function, and other indicators that inform your treatment protocol
The first two are approved medicines
It also keeps things interesting, variety is the spice of life as they say
The OASIS 4 trial described above studied adults with overweight or obesity without diabetes